EU FP7 EUWB - Enlarged Europe
|
PROJECT COMPLETED IN JULY 2011
EU FP7 type IP project financed by the European Commission from the 7th Framework Program (FP7-ICT- 258066):
EUWB – Enlarged (EUWB+) CoExisting Short Range Radio by Advanced Ultra-WideBand Radio Technology ― Enlarged European Union.
Duration: April 2010 - July 2011
The EUWB – Enlarged Europe consortium develops novel radio technologies, the aim of which is to enhance and demonstrate the functionality of mobile radio systems based on WiMedia (ECMA-368) standard. The ICT RC team focuses on the development of technologies in the following area:
a) architecture and protocols of a distributed CPC (DCPC) applied to the WiMedia (ECMA-368) based networks
Specific tasks where ICT RC is engaged:
WP2 Cognitive UWB Radio and Coexistence
Task 2.2 Definition and Design of the Architecture and Communication Mechanisms for a DCPC Applicable to UWB Environments
Project partners:
- GWT-TUD GmbH, Germany
- TES Electronic Solutions GmbH, Germany
- Philips Consumer Lifestyle B.V., The Netherlands
- Robert Bosch GmbH, Germany
- Commissariat à l’Energie Atomique, France
- Gottfried Wilhelm Leibniz Universität Hannover, Germany
- CREATE-NET, Italy
- University of Oulu, Finland
- EADS Deutschland GmbH, Germany
- Telefónica Investigación y Desarrollo Sociedad Anónima Unipersonal, Spain
- Thales Communications S.A., France
- VTT, Finland
- Wisair Ltd., Israel
- Universidad de Zaragoza, Spain
- ACORDE TECHNOLOGIES S.A., Spain
- TES Electronic Solutions Ltd., UK
- Alma Mater Studiorum – Università di Bologna, Italy
- Universität Duisburg-Essen, Germany
- Technische Universität Ilmenau, Germany
- Hochschule für Technik und Wirtschaft Dresden, Germany
- Artimi Ltd., UK
- FBConsulting S. à r.l., Luxembourg
- Bitgear Wireless Design Services d.o.o., Serbia
- České vysoké učení technické v Praze, Czech Republic
- Universitatea Politehnica din Bucuresti, Romania
- Wrocławskie Centrum Badań EIT+ Sp. z o.o. - Poland
Web page of EUWB - Enlarged: http:/www.euwb.eu
Did you know ...
The sizes of the viruses are from 30-300nm, whereas in the Biomed project, therapy through the use of RNA catalytic activity modulation is worked on.
more info